VEISEH, OMID,HEIDEBRECHT, RICHARD,WOTTON, PAUL KEVIN,OBERLI, MATTHIAS,MILLER, ROBERT JAMES
申请号：
CA3039203
公开号：
CA3039203A1
申请日:
2017.10.03
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The present invention provides compounds, e.g., compounds of Formula (I) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are implantable elements (e.g., devices and materials) comprising the same, as well as methods of use thereof, e.g., for treating or preventing a disease, disorder, or condition.
